Bench-to-bedside review: Hypothermia in traumatic brain injury
Open Access
- 1 January 2010
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 14 (1) , 204
Abstract
Traumatic brain injury remains a major cause of death and severe disability throughout the world. Traumatic brain injury leads to 1,000,000 hospital admissions per annum throughout the European Union. It causes the majority of the 50,000 deaths from road traffic accidents and leaves 10,000 patients severely handicapped: three quarters of these victims are young people. Therapeutic hypothermia has been shown to improve outcome after cardiac arrest, and consequently the European Resuscitation Council and American Heart Association guidelines recommend the use of hypothermia in these patients. Hypothermia is also thought to improve neurological outcome after neonatal birth asphyxia. Cardiac arrest and neonatal asphyxia patient populations present to health care services rapidly and without posing a diagnostic dilemma; therefore, therapeutic systemic hypothermia may be implemented relatively quickly. As a result, hypothermia in these two populations is similar to the laboratory models wherein systemic therapeutic hypothermia is commenced very soon after the injury and has shown so much promise. The need for resuscitation and computerised tomography imaging to confirm the diagnosis in patients with traumatic brain injury is a factor that delays intervention with temperature reduction strategies. Treatments in traumatic brain injury have traditionally focussed on restoring and maintaining adequate brain perfusion, surgically evacuating large haematomas where necessary, and preventing or promptly treating oedema. Brain swelling can be monitored by measuring intracranial pressure (ICP), and in most centres ICP is used to guide treatments and to monitor their success. There is an absence of evidence for the five commonly used treatments for raised ICP and all are potential 'double-edged swords' with significant disadvantages. The use of hypothermia in patients with traumatic brain injury may have beneficial effects in both ICP reduction and possible neuro-protection. This review will focus on the bench-to-bedside evidence that has supported the development of the Eurotherm3235Trial protocol.Keywords
This publication has 79 references indexed in Scilit:
- Induced hypothermia and fever control for prevention and treatment of neurological injuriesThe Lancet, 2008
- Hypothermia Treatment for Traumatic Brain Injury: A Systematic Review and Meta-AnalysisJournal of Neurotrauma, 2008
- εPKC May Contribute to the Protective Effect of Hypothermia in a Rat Focal Cerebral Ischemia ModelStroke, 2007
- Epidemiology and early predictive factors of mortality and outcome in children with traumatic severe brain injury: Experience of a French pediatric trauma center*Pediatric Critical Care Medicine, 2006
- Effect of Long-Term Mild Hypothermia or Short-Term Mild Hypothermia on Outcome of Patients with Severe Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2006
- Post-ischemic modest hypothermia (35°C) combined with intravenous magnesium is more effective at reducing CA1 neuronal death than either treatment used alone following global cerebral ischemia in ratsExperimental Neurology, 2005
- Effects of post‐injury hypothermia and nerve growth factor infusion on antioxidant enzyme activity in the rat: implications for clinical therapiesJournal of Neurochemistry, 2004
- Effect of long-term mild hypothermia therapy in patients with severe traumatic brain injury: 1-year follow-up review of 87 casesJournal of Neurosurgery, 2000
- EBIC-Guidelines for management of severe head injury in adultsActa Neurochirurgica, 1997
- Effect of moderate hypothermia on lipid peroxidation in canine brain tissue after cardiac arrest and resuscitation.Stroke, 1994